EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹498 Cr | ₹532 Cr | ₹662 Cr | ₹392 Cr | ₹84 Cr |
What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹498 Cr |
Mar2023 | ₹532 Cr |
Mar2022 | ₹662 Cr |
Mar2021 | ₹392 Cr |
Mar2020 | ₹84 Cr |
How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹498 Cr | -6.36 | |
Mar2023 | ₹532 Cr | -19.66 | |
Mar2022 | ₹662 Cr | 68.87 | |
Mar2021 | ₹392 Cr | 369.04 | |
Mar2020 | ₹84 Cr | - |
Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹25,845.0 Cr | 6.3% | 2.8% | -0.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 6.3% |
2.8% |
-0.1% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses